Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Obatala Sciences has commercialized its Fat-on-a-Chip system—a three-dimensional human adipose tissue culture model—for disease modeling and drug discovery. The company also offers adult human stem cells from diverse populations and hydrogels to support advanced preclinical research. Its products are used by pharmaceutical companies, biotech firms, academia, and government labs to improve the accuracy of preclinical studies in obesity, diabetes, cancer, metabolic disorders, and regenerative medicine. The pipeline includes additional organ/tissue chip models such as pancreas-on-a-chip under development.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Obatala Sciences.